Drugs / Amonafide

Trials 5 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/21 trial
Phase 1/2 NCT00087854 Mar 2004 → Dec 2005 prostate cancer Xanthus Pharmaceuticals, Inc. Completed No outcome recorded
Phase 23 trials
Phase 2 NCT01066494 Jan → Sep 2010 acute myeloid leukemia Antisoma Research Unknown No outcome recorded
Phase 2 NCT00273884 Aug 2005 → Apr 2009 acute myeloid leukemia Xanthus Pharmaceuticals, Inc. Completed No outcome recorded
Phase 2 NCT00074100 Aug 2003 → Sep 2004 breast cancer Memorial Sloan Kettering Cancer Center Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00715637 Jun 2007 → Jun 2010 acute myeloid leukemia Antisoma Research Unknown No outcome recorded

Evidence & citations 13 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as amonafide ClinicalTrials.gov intervention name — accepted as the source's own label NCT00074100
4

NCT00273884

NCT01066494

NCT00087854

NCT00715637

Known as Amonafida ChEMBL registry synonym — accepted as the source's own label CHEMBL428676
Known as AMONAFIDE CITRATE ChEMBL registry synonym — accepted as the source's own label CHEMBL428676
Known as Amonafide L-malate Amonafide L-malate (drug)” NCT00087854
Known as Amonafide malate ChEMBL registry synonym — accepted as the source's own label CHEMBL428676
Known as AS1413 “Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study” NCT00715637
Known as Nafidimide ChEMBL registry synonym — accepted as the source's own label CHEMBL428676
Known as NSC-308847 ChEMBL registry synonym — accepted as the source's own label CHEMBL428676
Known as XAN 02 ChEMBL registry synonym — accepted as the source's own label CHEMBL428676
Known as Xanafide ChEMBL registry synonym — accepted as the source's own label CHEMBL428676
Action Inhibit “Amonafide is a DNA intercalating agent and inhibitor of topoisomerase II” NCT00273884
Modality Small molecule CHEMBL428676
Route Intravenous “amonafide IV over 1 hour” NCT00074100